Objective: Peripheral arterial disease (PAD) affects nearly 8.5 million patients in the United States according to the Centers for Disease Control and Prevention. Although lifestyle modification and medical management can delay the rate of disease progression, approximately 5% of patients with PAD will eventually require revascularization. The most common complication of lower extremity bypass is surgical site infection (SSI), which can lead to prolonged hospital stays, additional procedures, and additive patient and hospital costs.
Methods: We analyzed data from 10,741 patients with PAD treated with open femoropopliteal bypass surgery collected from the National Surgical Quality Improvement Program (NSQIP) database from 2010 to 2016 using International Classification of Diseases and Current Procedural Terminology codes. c 2 tests and t-tests were used to compare preoperative risk factors. Logistic regression analysis was then used to correct for preoperative comorbidities. Analysis of strength of our model was performed using Hosmer-Lemeshow goodness of fit testing and receiver operating characteristic analysis.
Results: Overall in the NSQIP cohort, we found that the overall rate of any infection was 9.3%. Reported wound disruption was 1.7%. Superficial SSIs made up most of this number at 6.6%; deep incisional SSI was 2.2%, and organ/space SSI was 0.6%. Predictably, overall the strongest predictor of any SSI was the presence of diabetes, with a 29.5% increase in SSI with non-insulin dependence (adjusted odds ratio [aOR], 1.29; 95% confidence interval [CI], 1.09-1.54; P ¼ .004) and a 68.3% increase with insulin dependence (aOR, 1.68; 95% CI, 1.44-1.96; P < .001). A history of chronic obstructive pulmonary disease was the second most important factor with a 43.6% increase in incidence of SSI (aOR, 1.44; 95% CI, 1.21-1.71; P < .001). Surprisingly, a history of smoking within 1 year did not dramatically increase the risk of SSI, with only a 19.4% increase in incidence (aOR, 1.19; 95% CI, 1.04-1.36; P ¼ .01).
Conclusions: Femoropopliteal bypass is the "gold standard" for treatment of femoral PAD. With the prevalence of endovascular treatment, analysis of the most recent NSQIP data finds some interesting trends as to risk factors for development of SSI with femoropopliteal bypass. The overall rate of SSI is much higher than in other reported studies in the literature at 9.3%, which might be a contribution of endovascular treatment for healthier patients.
Author Disclosures: C. Das: Nothing to disclose; M. Nazzal: Nothing to disclose; M. Adair: Nothing to disclose; S. Markowiak: Nothing to disclose; M. Omar: Nothing to disclose; S. Gregory: Nothing to disclose. Objective: Interventional strategies for acute limb ischemia continue to evolve. Most studies have focused on the comparison between thrombolytic therapy and surgical revascularization. However, limited data exist on the use of novel vacuum-assisted thrombectomy (VAT) devices. The purpose of this study was to evaluate the outcomes of patients who have undergone VAT at our institution. Lower extremity bypass occlusion 11 15
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Methods: A retrospective review was conducted from 2014 to 2018 of patients who presented to our institution with acute limb ischemia and underwent VAT. Primary outcome was safety and efficacy of VAT. Safety was measured by variables including estimated blood loss, distal embolization, need for transfusion, or other vessel pathologic occurrences. Efficacy was determined by presence of antegrade flow on angiography. Secondary outcome included need for adjunctive intervention in addition to VAT.
Results: A total of 73 patients (48 male; mean age, 65.6 years) were evaluated in the study (Table I) ; 68 cases (93%) had an estimated blood loss of <300 mL (Table II) . The five cases with estimated blood loss >300 mL (6.8%) were associated with endovascular and open adjunctive interventions (Table II). Two cases (2.7%) were complicated by distal embolization, and six (8.2%) required transfusion of blood products (Table II) . Each case requiring transfusion included catheter-directed thrombolysis as part of the intervention. In terms of efficacy, 62 cases achieved antegrade flow (84.9%; Table II) .
Conclusions: These initial results suggest that VAT is safe and can provide a means of achieving antegrade flow in the management of acute limb ischemia. Further analysis is needed to evaluate VAT's efficacy alone vs when it is combined with other adjunctive interventions. In addition, this suggests that further studies should be performed looking specifically at endovascular management using VAT for Rutherford IIb ischemia. Background: Compartment syndrome is one of the true emergencies in vascular and orthopedic surgery. Surgical treatment of this condition is mandated to prevent nerve and eventually further function loss. Traditional teaching and practice of prophylactic fasciotomy after revascularization in acute ischemia are still performed after certain criteria are met. Patients with longer ischemia time and concomitant artery and vein injury will get fasciotomy. Fasciotomy is a relatively morbid and debilitating procedure that may cause disability and permanent damage to nerves and limb function. In this case series, eight cases of acute ischemia of the lower extremity were treated surgically by thromboembolectomy (seven cases) or bypass (one case). Because of the small muscle mass of most of the patients and no immediate change after revascularization, it was decided to perform fasciotomy on the basis of neurovascular and clinical changes in the early postoperative period. Only one of the patients required re-exploration for evacuation of hematoma. Ischemia time was between 2 and 48 hours. It was noted that patients who had advanced age with lower body mass index did not require fasciotomy even after longer ischemia time.
Methods: A retrospective review of acute limb ischemia patients at a single institution from 2016 to 2018 was performed to determine the impact of revascularization on compartment syndrome development. Eight patients with acute lower extremity ischemia underwent embolectomy and revascularization during 2016 to March 2018. The affected lower extremity of all patients was monitored for changes in swelling and neurosensory function. Judgment was based on swelling and stiffness of the lower leg compartment.
Results: Mean age of these patients was 79 years (53-103 years). Average body mass index was 24.2 kg/m 2 (18-29 kg/m 2 ). Conclusions: Prophylactic fasciotomy could be avoided in female patients with advanced age and small muscle mass. In these cases, compartment syndrome did not develop even after long ischemia time and some degree of motor function loss. This required close neurovascular monitoring in the perioperative period. Further investigation is required to improve outcome of revascularization in acute limb ischemia. A selective group of patients with acute limb ischemia may benefit from monitoring rather than early "prophylactic" fasciotomy. Objective: The drug-coated balloon (DCB) is widely employed in treatment of peripheral arterial disease. Treatment outcomes of DCB in patients with critical limb ischemia (CLI) are still lacking. The objective of this study was to compare and to assess clinical outcomes of DCB treatment vs standard angioplasty and stenting (SAS) in patients with CLI.
Methods: Patients with CLI who have undergone endovascular interventions for femoropopliteal artery occlusive disease between 2013 and 2017 were identified retrospectively from an institutional database. Relevant patient data and clinical outcomes were collected and compared between DCB and SAS. Primary outcomes assessed and compared included target limb salvage rates, patency, and frequency of secondary interventions (SIs). Univariate and multivariate analyses were used to determine predictors of major amputations and SI.
Results: During the study period, 122 patients with CLI were identified who underwent endovascular treatment of primary femoropopliteal disease (DCB, 58; SAS, 64) . Mean lesion length treated was 14.7 cm (standard deviation, 8.9 cm) in the SAS group vs 13.7 cm (standard deviation, 7.8 cm) in the DCB group (P ¼ .317). Overall 12-month target limb salvage rate was not statistically different between DCB (87%) and SAS (83%; P ¼ .168). The 6-month and 12-month freedom from SI was 84% and 75%, respectively, with DCB vs 85% and 70%, respectively, for SAS (P ¼ .651). Female sex (hazard ratio, 2.1; P ¼ .02) and higher TransAtlantic Inter-Society Consensus classifications (hazard ratio, 1.8; P ¼ .035) were significant risk factors for reintervention. One-year mortality in the cohort was 48%.
Conclusions: DCB treatment demonstrates noninferiority compared with SAS in CLI patients, but definitive efficacy cannot be supported by these data. Female sex and higher TransAtlantic Inter-Society Consensus classification of lesions were associated with higher risk of reinterventions after DCB or SAS.
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In Search of the Right Tool: Using a Standardized Risk Calculator to Predict Groin Wound Infection Liska L. Havel, MD, Andrew J. Borgert, PhD, Kara J. Kallies, Irina Shakhnovich, MD. Surgery, Gundersen Health System, La Crosse, WI Objective: Surgical site infection (SSI), particularly involving groin exposure during lower extremity revascularization, remains a challenge for vascular surgeons. Groin SSI is associated with limb loss, increased mortality, and cost of care. A useful tool to the vascular surgeon would be a standardized risk calculator that can help identify patients at risk and potentially prevent future complications. In this study, we test the Penn 
